Suppr超能文献

正常和恶性造血过程中的微小RNA

miRNAs in Normal and Malignant Hematopoiesis.

作者信息

Kotaki Ryutaro, Koyama-Nasu Ryo, Yamakawa Natsuko, Kotani Ai

机构信息

Department of Hematology and Oncology, Tokai University School of Medicine, Hiratsuka 259-1193, Japan.

出版信息

Int J Mol Sci. 2017 Jul 11;18(7):1495. doi: 10.3390/ijms18071495.

Abstract

Lineage specification is primarily regulated at the transcriptional level and lineage-specific transcription factors determine cell fates. MicroRNAs (miRNAs) are 18-24 nucleotide-long non-coding RNAs that post-transcriptionally decrease the translation of target mRNAs and are essential for many cellular functions. miRNAs also regulate lineage specification during hematopoiesis. This review highlights the roles of miRNAs in B-cell development and malignancies, and discusses how miRNA expression profiles correlate with disease prognoses and phenotypes. We also discuss the potential for miRNAs as therapeutic targets and diagnostic tools for B-cell malignancies.

摘要

谱系特化主要在转录水平受到调控,谱系特异性转录因子决定细胞命运。微小RNA(miRNA)是长度为18 - 24个核苷酸的非编码RNA,它们在转录后水平降低靶mRNA的翻译,并且对许多细胞功能至关重要。miRNA在造血过程中也调节谱系特化。本综述重点介绍了miRNA在B细胞发育和恶性肿瘤中的作用,并讨论了miRNA表达谱如何与疾病预后和表型相关。我们还讨论了miRNA作为B细胞恶性肿瘤治疗靶点和诊断工具的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ff2/5535985/9d9b85297c21/ijms-18-01495-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验